A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide

PURPOSE: To investigate whether palonosetron is better than granisetron in preventing chemotherapy‐induced nausea and vomiting (CINV) in a three‐drug combination with dexamethasone and fosaprepitant (Fos) in patients with breast cancer who are placed on anthracycline and cyclophosphamide (AC‐based r...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Koji, Takahashi, Masato, Sato, Kazuhiko, Osaki, Akihiko, Takano, Toshimi, Naito, Yoichi, Matsuura, Kazuo, Aogi, Kenjiro, Fujiwara, Kimiko, Tamura, Kenji, Baba, Motoi, Tokunaga, Shinya, Hirano, Gen, Imoto, Shigeru, Miyazaki, Chieko, Yanagihara, Kazuhiro, Imamura, Chiyo K., Chiba, Yasutaka, Saeki, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221309/
https://www.ncbi.nlm.nih.gov/pubmed/32168551
http://dx.doi.org/10.1002/cam4.2979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221309/
https://www.ncbi.nlm.nih.gov/pubmed/32168551
http://dx.doi.org/10.1002/cam4.2979

Ejemplares similares